nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—HTR2A—pancreatitis	0.637	1	CbGaD
Nefazodone—Angle closure glaucoma—Hyoscyamine—pancreatitis	0.0124	0.0527	CcSEcCtD
Nefazodone—Accommodation disorder—Propantheline—pancreatitis	0.0113	0.0483	CcSEcCtD
Nefazodone—Mydriasis—Propantheline—pancreatitis	0.00816	0.0348	CcSEcCtD
Nefazodone—Salivary hypersecretion—Propantheline—pancreatitis	0.00632	0.0269	CcSEcCtD
Nefazodone—Accommodation disorder—Hyoscyamine—pancreatitis	0.0058	0.0247	CcSEcCtD
Nefazodone—Keratitis—Hyoscyamine—pancreatitis	0.00514	0.0219	CcSEcCtD
Nefazodone—Thirst—Propantheline—pancreatitis	0.00496	0.0211	CcSEcCtD
Nefazodone—Paranoia—Hyoscyamine—pancreatitis	0.00489	0.0208	CcSEcCtD
Nefazodone—Laryngitis—Hyoscyamine—pancreatitis	0.00462	0.0197	CcSEcCtD
Nefazodone—Mydriasis—Hyoscyamine—pancreatitis	0.00418	0.0178	CcSEcCtD
Nefazodone—Ageusia—Hyoscyamine—pancreatitis	0.00411	0.0175	CcSEcCtD
Nefazodone—Abdominal distension—Propantheline—pancreatitis	0.00411	0.0175	CcSEcCtD
Nefazodone—Dysphagia—Propantheline—pancreatitis	0.00408	0.0174	CcSEcCtD
Nefazodone—Erectile dysfunction—Propantheline—pancreatitis	0.00376	0.016	CcSEcCtD
Nefazodone—Ventricular extrasystoles—Hyoscyamine—pancreatitis	0.00369	0.0157	CcSEcCtD
Nefazodone—Dysarthria—Hyoscyamine—pancreatitis	0.00352	0.015	CcSEcCtD
Nefazodone—Muscle twitching—Hyoscyamine—pancreatitis	0.00339	0.0145	CcSEcCtD
Nefazodone—Photophobia—Hyoscyamine—pancreatitis	0.00313	0.0133	CcSEcCtD
Nefazodone—Dry eye—Hyoscyamine—pancreatitis	0.00308	0.0131	CcSEcCtD
Nefazodone—Flushing—Propantheline—pancreatitis	0.00303	0.0129	CcSEcCtD
Nefazodone—Rash maculo-papular—Hyoscyamine—pancreatitis	0.00303	0.0129	CcSEcCtD
Nefazodone—Hypertonia—Hyoscyamine—pancreatitis	0.00292	0.0124	CcSEcCtD
Nefazodone—Hyperkinesia—Hyoscyamine—pancreatitis	0.0029	0.0124	CcSEcCtD
Nefazodone—Eczema—Hyoscyamine—pancreatitis	0.00269	0.0115	CcSEcCtD
Nefazodone—Vision blurred—Propantheline—pancreatitis	0.00268	0.0114	CcSEcCtD
Nefazodone—Eye pain—Hyoscyamine—pancreatitis	0.00268	0.0114	CcSEcCtD
Nefazodone—Thirst—Hyoscyamine—pancreatitis	0.00254	0.0108	CcSEcCtD
Nefazodone—Palpitations—Propantheline—pancreatitis	0.00251	0.0107	CcSEcCtD
Nefazodone—Hypoglycaemia—Hyoscyamine—pancreatitis	0.00248	0.0106	CcSEcCtD
Nefazodone—Hyponatraemia—Hyoscyamine—pancreatitis	0.00243	0.0103	CcSEcCtD
Nefazodone—Osteoarthritis—Hyoscyamine—pancreatitis	0.00242	0.0103	CcSEcCtD
Nefazodone—Dry mouth—Propantheline—pancreatitis	0.00237	0.0101	CcSEcCtD
Nefazodone—Confusional state—Propantheline—pancreatitis	0.00234	0.00997	CcSEcCtD
Nefazodone—Anaphylactic shock—Propantheline—pancreatitis	0.00232	0.00989	CcSEcCtD
Nefazodone—Urinary retention—Hyoscyamine—pancreatitis	0.0023	0.0098	CcSEcCtD
Nefazodone—Ataxia—Hyoscyamine—pancreatitis	0.00227	0.00969	CcSEcCtD
Nefazodone—Tachycardia—Propantheline—pancreatitis	0.00227	0.00966	CcSEcCtD
Nefazodone—Dehydration—Hyoscyamine—pancreatitis	0.00225	0.00958	CcSEcCtD
Nefazodone—Dry skin—Hyoscyamine—pancreatitis	0.00222	0.00944	CcSEcCtD
Nefazodone—Abdominal distension—Hyoscyamine—pancreatitis	0.0021	0.00897	CcSEcCtD
Nefazodone—Insomnia—Propantheline—pancreatitis	0.0021	0.00895	CcSEcCtD
Nefazodone—Dysphagia—Hyoscyamine—pancreatitis	0.00209	0.00891	CcSEcCtD
Nefazodone—Somnolence—Propantheline—pancreatitis	0.00206	0.00879	CcSEcCtD
Nefazodone—Angina pectoris—Hyoscyamine—pancreatitis	0.00204	0.00867	CcSEcCtD
Nefazodone—Constipation—Propantheline—pancreatitis	0.00199	0.00846	CcSEcCtD
Nefazodone—Dysuria—Hyoscyamine—pancreatitis	0.00195	0.00833	CcSEcCtD
Nefazodone—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00192	0.0082	CcSEcCtD
Nefazodone—Feeling abnormal—Propantheline—pancreatitis	0.00191	0.00815	CcSEcCtD
Nefazodone—Urticaria—Propantheline—pancreatitis	0.00184	0.00786	CcSEcCtD
Nefazodone—Conjunctivitis—Hyoscyamine—pancreatitis	0.00181	0.00772	CcSEcCtD
Nefazodone—Sweating—Hyoscyamine—pancreatitis	0.00179	0.00761	CcSEcCtD
Nefazodone—Hypersensitivity—Propantheline—pancreatitis	0.00171	0.00729	CcSEcCtD
Nefazodone—Bradycardia—Hyoscyamine—pancreatitis	0.0017	0.00726	CcSEcCtD
Nefazodone—Asthenia—Propantheline—pancreatitis	0.00167	0.0071	CcSEcCtD
Nefazodone—Hallucination—Hyoscyamine—pancreatitis	0.00166	0.00709	CcSEcCtD
Nefazodone—Flushing—Hyoscyamine—pancreatitis	0.00155	0.00662	CcSEcCtD
Nefazodone—Dizziness—Propantheline—pancreatitis	0.00154	0.00654	CcSEcCtD
Nefazodone—Vomiting—Propantheline—pancreatitis	0.00148	0.00629	CcSEcCtD
Nefazodone—Rash—Propantheline—pancreatitis	0.00146	0.00624	CcSEcCtD
Nefazodone—Dermatitis—Propantheline—pancreatitis	0.00146	0.00623	CcSEcCtD
Nefazodone—Headache—Propantheline—pancreatitis	0.00145	0.0062	CcSEcCtD
Nefazodone—Dysgeusia—Hyoscyamine—pancreatitis	0.00143	0.00608	CcSEcCtD
Nefazodone—Nausea—Propantheline—pancreatitis	0.00138	0.00588	CcSEcCtD
Nefazodone—Vision blurred—Hyoscyamine—pancreatitis	0.00137	0.00585	CcSEcCtD
Nefazodone—Agitation—Hyoscyamine—pancreatitis	0.00134	0.0057	CcSEcCtD
Nefazodone—Angioedema—Hyoscyamine—pancreatitis	0.00133	0.00567	CcSEcCtD
Nefazodone—Trifluoperazine—XDH—pancreatitis	0.00131	0.243	CrCbGaD
Nefazodone—Vertigo—Hyoscyamine—pancreatitis	0.00131	0.00557	CcSEcCtD
Nefazodone—Syncope—Hyoscyamine—pancreatitis	0.00131	0.00556	CcSEcCtD
Nefazodone—Palpitations—Hyoscyamine—pancreatitis	0.00129	0.00548	CcSEcCtD
Nefazodone—Loss of consciousness—Hyoscyamine—pancreatitis	0.00128	0.00545	CcSEcCtD
Nefazodone—Convulsion—Hyoscyamine—pancreatitis	0.00126	0.00538	CcSEcCtD
Nefazodone—Chest pain—Hyoscyamine—pancreatitis	0.00124	0.00528	CcSEcCtD
Nefazodone—Anxiety—Hyoscyamine—pancreatitis	0.00124	0.00526	CcSEcCtD
Nefazodone—Dry mouth—Hyoscyamine—pancreatitis	0.00121	0.00517	CcSEcCtD
Nefazodone—Confusional state—Hyoscyamine—pancreatitis	0.0012	0.00511	CcSEcCtD
Nefazodone—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00119	0.00506	CcSEcCtD
Nefazodone—Oedema—Hyoscyamine—pancreatitis	0.00119	0.00506	CcSEcCtD
Nefazodone—Shock—Hyoscyamine—pancreatitis	0.00117	0.00498	CcSEcCtD
Nefazodone—Tachycardia—Hyoscyamine—pancreatitis	0.00116	0.00494	CcSEcCtD
Nefazodone—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00115	0.0049	CcSEcCtD
Nefazodone—Hypotension—Hyoscyamine—pancreatitis	0.00111	0.00473	CcSEcCtD
Nefazodone—Insomnia—Hyoscyamine—pancreatitis	0.00107	0.00458	CcSEcCtD
Nefazodone—Dyspnoea—Hyoscyamine—pancreatitis	0.00106	0.00451	CcSEcCtD
Nefazodone—Somnolence—Hyoscyamine—pancreatitis	0.00106	0.0045	CcSEcCtD
Nefazodone—Dyspepsia—Hyoscyamine—pancreatitis	0.00105	0.00446	CcSEcCtD
Nefazodone—Pain—Hyoscyamine—pancreatitis	0.00102	0.00433	CcSEcCtD
Nefazodone—Constipation—Hyoscyamine—pancreatitis	0.00102	0.00433	CcSEcCtD
Nefazodone—Feeling abnormal—Hyoscyamine—pancreatitis	0.000979	0.00417	CcSEcCtD
Nefazodone—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000972	0.00414	CcSEcCtD
Nefazodone—Urticaria—Hyoscyamine—pancreatitis	0.000944	0.00402	CcSEcCtD
Nefazodone—Body temperature increased—Hyoscyamine—pancreatitis	0.000939	0.004	CcSEcCtD
Nefazodone—Abdominal pain—Hyoscyamine—pancreatitis	0.000939	0.004	CcSEcCtD
Nefazodone—Hypersensitivity—Hyoscyamine—pancreatitis	0.000876	0.00373	CcSEcCtD
Nefazodone—Asthenia—Hyoscyamine—pancreatitis	0.000853	0.00363	CcSEcCtD
Nefazodone—Pruritus—Hyoscyamine—pancreatitis	0.000841	0.00358	CcSEcCtD
Nefazodone—Diarrhoea—Hyoscyamine—pancreatitis	0.000813	0.00346	CcSEcCtD
Nefazodone—Dizziness—Hyoscyamine—pancreatitis	0.000786	0.00335	CcSEcCtD
Nefazodone—Vomiting—Hyoscyamine—pancreatitis	0.000756	0.00322	CcSEcCtD
Nefazodone—Rash—Hyoscyamine—pancreatitis	0.000749	0.00319	CcSEcCtD
Nefazodone—Dermatitis—Hyoscyamine—pancreatitis	0.000749	0.00319	CcSEcCtD
Nefazodone—Headache—Hyoscyamine—pancreatitis	0.000744	0.00317	CcSEcCtD
Nefazodone—Nausea—Hyoscyamine—pancreatitis	0.000706	0.00301	CcSEcCtD
Nefazodone—Zuclopenthixol—HTR2A—pancreatitis	0.000599	0.111	CrCbGaD
Nefazodone—Aripiprazole—HTR2A—pancreatitis	0.000554	0.102	CrCbGaD
Nefazodone—Trazodone—HTR2A—pancreatitis	0.000551	0.102	CrCbGaD
Nefazodone—Thioproperazine—HTR2A—pancreatitis	0.000525	0.0971	CrCbGaD
Nefazodone—Fluphenazine—HTR2A—pancreatitis	0.000446	0.0826	CrCbGaD
Nefazodone—Thioproperazine—ALB—pancreatitis	0.000359	0.0665	CrCbGaD
Nefazodone—Trifluoperazine—HTR2A—pancreatitis	0.000357	0.066	CrCbGaD
Nefazodone—Perphenazine—HTR2A—pancreatitis	0.000353	0.0653	CrCbGaD
Nefazodone—Quetiapine—HTR2A—pancreatitis	0.000346	0.064	CrCbGaD
Nefazodone—HTR2C—Signaling Pathways—SST—pancreatitis	2.98e-05	0.000242	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR2A—pancreatitis	2.97e-05	0.000242	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCKAR—pancreatitis	2.97e-05	0.000242	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PPP3CA—pancreatitis	2.97e-05	0.000242	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DUSP6—pancreatitis	2.97e-05	0.000242	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DUSP6—pancreatitis	2.95e-05	0.00024	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—FDX1—pancreatitis	2.88e-05	0.000235	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SST—pancreatitis	2.85e-05	0.000232	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL5—pancreatitis	2.85e-05	0.000232	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	2.84e-05	0.000231	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SMO—pancreatitis	2.83e-05	0.00023	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTHLH—pancreatitis	2.83e-05	0.00023	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DUSP6—pancreatitis	2.82e-05	0.00023	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—BDKRB2—pancreatitis	2.81e-05	0.000229	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	2.81e-05	0.000229	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—BDKRB2—pancreatitis	2.8e-05	0.000228	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SMO—pancreatitis	2.77e-05	0.000225	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTHLH—pancreatitis	2.77e-05	0.000225	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—FGA—pancreatitis	2.76e-05	0.000225	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—FGB—pancreatitis	2.76e-05	0.000225	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR2A—pancreatitis	2.76e-05	0.000225	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CNR1—pancreatitis	2.76e-05	0.000225	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CNR1—pancreatitis	2.75e-05	0.000224	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—FGB—pancreatitis	2.71e-05	0.000221	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR2A—pancreatitis	2.7e-05	0.00022	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PPP3CA—pancreatitis	2.7e-05	0.00022	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADH4—pancreatitis	2.68e-05	0.000218	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—BDKRB2—pancreatitis	2.68e-05	0.000218	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—GCG—pancreatitis	2.67e-05	0.000217	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—GCG—pancreatitis	2.65e-05	0.000216	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PPP3CA—pancreatitis	2.64e-05	0.000215	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CNR1—pancreatitis	2.63e-05	0.000214	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PLA2G1B—pancreatitis	2.59e-05	0.000211	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SST—pancreatitis	2.58e-05	0.00021	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTHLH—pancreatitis	2.57e-05	0.000209	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SMO—pancreatitis	2.57e-05	0.000209	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DUSP6—pancreatitis	2.56e-05	0.000209	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—KNG1—pancreatitis	2.56e-05	0.000208	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—KNG1—pancreatitis	2.55e-05	0.000207	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GCG—pancreatitis	2.54e-05	0.000207	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SST—pancreatitis	2.53e-05	0.000206	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PRSS1—pancreatitis	2.52e-05	0.000205	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—FGB—pancreatitis	2.52e-05	0.000205	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR2A—pancreatitis	2.51e-05	0.000204	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DUSP6—pancreatitis	2.51e-05	0.000204	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GCG—pancreatitis	2.51e-05	0.000204	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—A2M—pancreatitis	2.5e-05	0.000204	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CCL2—pancreatitis	2.5e-05	0.000203	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—LPL—pancreatitis	2.49e-05	0.000203	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CCL2—pancreatitis	2.48e-05	0.000202	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PPP3CA—pancreatitis	2.45e-05	0.0002	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PLA2G1B—pancreatitis	2.44e-05	0.000199	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—KNG1—pancreatitis	2.44e-05	0.000198	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—BDKRB2—pancreatitis	2.43e-05	0.000198	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PRSS3—pancreatitis	2.39e-05	0.000195	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PNLIP—pancreatitis	2.39e-05	0.000195	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CNR1—pancreatitis	2.38e-05	0.000194	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—BDKRB2—pancreatitis	2.38e-05	0.000194	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CCL2—pancreatitis	2.38e-05	0.000194	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—A2M—pancreatitis	2.36e-05	0.000192	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PDGFA—pancreatitis	2.35e-05	0.000192	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SST—pancreatitis	2.35e-05	0.000192	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PDGFA—pancreatitis	2.34e-05	0.000191	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CNR1—pancreatitis	2.34e-05	0.00019	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DUSP6—pancreatitis	2.33e-05	0.00019	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GCG—pancreatitis	2.3e-05	0.000188	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GCG—pancreatitis	2.3e-05	0.000187	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALDH2—pancreatitis	2.29e-05	0.000186	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GCG—pancreatitis	2.26e-05	0.000184	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PDGFA—pancreatitis	2.24e-05	0.000183	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—KNG1—pancreatitis	2.21e-05	0.00018	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—BDKRB2—pancreatitis	2.21e-05	0.00018	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CXCL8—pancreatitis	2.17e-05	0.000177	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CNR1—pancreatitis	2.17e-05	0.000177	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—NRAS—pancreatitis	2.17e-05	0.000177	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—KNG1—pancreatitis	2.16e-05	0.000176	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CXCL8—pancreatitis	2.16e-05	0.000176	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCL2—pancreatitis	2.16e-05	0.000176	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALDH2—pancreatitis	2.15e-05	0.000176	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—XDH—pancreatitis	2.14e-05	0.000175	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL5—pancreatitis	2.14e-05	0.000174	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL5—pancreatitis	2.13e-05	0.000173	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCL2—pancreatitis	2.11e-05	0.000172	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GCG—pancreatitis	2.1e-05	0.000171	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LPL—pancreatitis	2.09e-05	0.00017	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LPL—pancreatitis	2.08e-05	0.00017	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CXCL8—pancreatitis	2.07e-05	0.000169	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL5—pancreatitis	2.04e-05	0.000166	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PDGFA—pancreatitis	2.03e-05	0.000166	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TGFB1—pancreatitis	2.01e-05	0.000164	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—KNG1—pancreatitis	2.01e-05	0.000164	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADH1B—pancreatitis	2e-05	0.000163	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LPL—pancreatitis	1.99e-05	0.000162	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PDGFA—pancreatitis	1.99e-05	0.000162	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SPP1—pancreatitis	1.98e-05	0.000161	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CXCL8—pancreatitis	1.97e-05	0.000161	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SPP1—pancreatitis	1.97e-05	0.000161	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—LPL—pancreatitis	1.97e-05	0.00016	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CXCL8—pancreatitis	1.96e-05	0.00016	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL2—pancreatitis	1.96e-05	0.00016	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.91e-05	0.000155	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SPP1—pancreatitis	1.89e-05	0.000154	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2A—pancreatitis	1.89e-05	0.000154	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCL8—pancreatitis	1.88e-05	0.000153	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCL8—pancreatitis	1.88e-05	0.000153	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2A—pancreatitis	1.88e-05	0.000153	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—KRAS—pancreatitis	1.87e-05	0.000152	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PDGFA—pancreatitis	1.85e-05	0.000151	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL5—pancreatitis	1.85e-05	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCL8—pancreatitis	1.84e-05	0.00015	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PPARG—pancreatitis	1.82e-05	0.000148	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL5—pancreatitis	1.81e-05	0.000147	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LPL—pancreatitis	1.81e-05	0.000147	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—LPL—pancreatitis	1.8e-05	0.000147	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2A—pancreatitis	1.8e-05	0.000146	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—INS—pancreatitis	1.79e-05	0.000145	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LPL—pancreatitis	1.77e-05	0.000144	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LEP—pancreatitis	1.75e-05	0.000143	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LEP—pancreatitis	1.74e-05	0.000142	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GCG—pancreatitis	1.73e-05	0.000141	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SPP1—pancreatitis	1.71e-05	0.000139	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCL8—pancreatitis	1.71e-05	0.000139	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	1.7e-05	0.000139	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL5—pancreatitis	1.68e-05	0.000137	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SPP1—pancreatitis	1.68e-05	0.000137	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LEP—pancreatitis	1.67e-05	0.000136	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCL8—pancreatitis	1.67e-05	0.000136	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LPL—pancreatitis	1.64e-05	0.000134	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—pancreatitis	1.64e-05	0.000133	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GCG—pancreatitis	1.63e-05	0.000133	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2A—pancreatitis	1.6e-05	0.00013	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.59e-05	0.00013	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—HRAS—pancreatitis	1.59e-05	0.000129	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—NRAS—pancreatitis	1.58e-05	0.000129	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—NRAS—pancreatitis	1.57e-05	0.000128	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SPP1—pancreatitis	1.56e-05	0.000127	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCL8—pancreatitis	1.55e-05	0.000126	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—A2M—pancreatitis	1.54e-05	0.000125	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LEP—pancreatitis	1.51e-05	0.000123	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—NRAS—pancreatitis	1.51e-05	0.000123	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—INS—pancreatitis	1.5e-05	0.000122	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—INS—pancreatitis	1.49e-05	0.000121	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LEP—pancreatitis	1.48e-05	0.000121	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2A—pancreatitis	1.48e-05	0.000121	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL2—pancreatitis	1.47e-05	0.00012	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL2—pancreatitis	1.47e-05	0.000119	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPARG—pancreatitis	1.44e-05	0.000117	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—pancreatitis	1.43e-05	0.000117	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—INS—pancreatitis	1.43e-05	0.000116	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALDH2—pancreatitis	1.41e-05	0.000115	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—INS—pancreatitis	1.41e-05	0.000115	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL2—pancreatitis	1.4e-05	0.000114	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LEP—pancreatitis	1.38e-05	0.000112	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—NRAS—pancreatitis	1.37e-05	0.000111	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—KRAS—pancreatitis	1.36e-05	0.000111	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—LPL—pancreatitis	1.36e-05	0.000111	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—KRAS—pancreatitis	1.36e-05	0.00011	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—NRAS—pancreatitis	1.34e-05	0.000109	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARG—pancreatitis	1.32e-05	0.000107	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—KRAS—pancreatitis	1.3e-05	0.000106	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—INS—pancreatitis	1.29e-05	0.000105	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—pancreatitis	1.29e-05	0.000105	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—INS—pancreatitis	1.29e-05	0.000105	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—LPL—pancreatitis	1.28e-05	0.000104	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—pancreatitis	1.27e-05	0.000104	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—INS—pancreatitis	1.27e-05	0.000103	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—pancreatitis	1.25e-05	0.000102	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MDM2—pancreatitis	1.25e-05	0.000102	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—NRAS—pancreatitis	1.24e-05	0.000101	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MDM2—pancreatitis	1.24e-05	0.000101	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MDM2—pancreatitis	1.19e-05	9.67e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—pancreatitis	1.18e-05	9.64e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—INS—pancreatitis	1.18e-05	9.59e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—KRAS—pancreatitis	1.18e-05	9.59e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL8—pancreatitis	1.17e-05	9.49e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL8—pancreatitis	1.16e-05	9.44e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—pancreatitis	1.16e-05	9.44e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HRAS—pancreatitis	1.16e-05	9.43e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—KRAS—pancreatitis	1.15e-05	9.39e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HRAS—pancreatitis	1.15e-05	9.38e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—pancreatitis	1.13e-05	9.2e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CASP3—pancreatitis	1.12e-05	9.09e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL8—pancreatitis	1.11e-05	9.04e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CASP3—pancreatitis	1.11e-05	9.04e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—pancreatitis	1.11e-05	9.03e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HRAS—pancreatitis	1.1e-05	8.98e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—pancreatitis	1.1e-05	8.98e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MDM2—pancreatitis	1.08e-05	8.77e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—KRAS—pancreatitis	1.07e-05	8.72e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GCG—pancreatitis	1.07e-05	8.7e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CASP3—pancreatitis	1.06e-05	8.65e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—pancreatitis	1.06e-05	8.6e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MDM2—pancreatitis	1.05e-05	8.59e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—pancreatitis	1.03e-05	8.43e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL8—pancreatitis	1.01e-05	8.2e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HRAS—pancreatitis	1e-05	8.15e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARG—pancreatitis	9.93e-06	8.09e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL8—pancreatitis	9.86e-06	8.03e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MDM2—pancreatitis	9.8e-06	7.98e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HRAS—pancreatitis	9.79e-06	7.98e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—INS—pancreatitis	9.74e-06	7.93e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CASP3—pancreatitis	9.64e-06	7.85e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—pancreatitis	9.57e-06	7.8e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CASP3—pancreatitis	9.44e-06	7.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—pancreatitis	9.37e-06	7.64e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARG—pancreatitis	9.36e-06	7.62e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NRAS—pancreatitis	9.35e-06	7.62e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NRAS—pancreatitis	9.3e-06	7.58e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—INS—pancreatitis	9.18e-06	7.47e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL8—pancreatitis	9.16e-06	7.46e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HRAS—pancreatitis	9.1e-06	7.41e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—pancreatitis	8.93e-06	7.27e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NRAS—pancreatitis	8.9e-06	7.25e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CASP3—pancreatitis	8.77e-06	7.14e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—pancreatitis	8.71e-06	7.09e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—pancreatitis	8.69e-06	7.08e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—pancreatitis	8.64e-06	7.04e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—pancreatitis	8.41e-06	6.85e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LPL—pancreatitis	8.38e-06	6.82e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—pancreatitis	8.27e-06	6.74e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NRAS—pancreatitis	8.08e-06	6.58e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—KRAS—pancreatitis	8.05e-06	6.55e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—KRAS—pancreatitis	8.01e-06	6.52e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NRAS—pancreatitis	7.91e-06	6.44e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—pancreatitis	7.81e-06	6.36e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—KRAS—pancreatitis	7.66e-06	6.24e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—pancreatitis	7.5e-06	6.11e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—pancreatitis	7.36e-06	5.99e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—pancreatitis	7.35e-06	5.99e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NRAS—pancreatitis	7.35e-06	5.99e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—KRAS—pancreatitis	6.95e-06	5.66e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HRAS—pancreatitis	6.84e-06	5.57e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—pancreatitis	6.83e-06	5.56e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—KRAS—pancreatitis	6.81e-06	5.54e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HRAS—pancreatitis	6.8e-06	5.54e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—pancreatitis	6.55e-06	5.33e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HRAS—pancreatitis	6.51e-06	5.31e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—pancreatitis	6.51e-06	5.3e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—KRAS—pancreatitis	6.32e-06	5.15e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—pancreatitis	6.23e-06	5.08e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARG—pancreatitis	6.12e-06	4.98e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—INS—pancreatitis	6e-06	4.89e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HRAS—pancreatitis	5.91e-06	4.81e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HRAS—pancreatitis	5.79e-06	4.71e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—pancreatitis	5.66e-06	4.61e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—pancreatitis	5.54e-06	4.51e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—pancreatitis	5.5e-06	4.48e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HRAS—pancreatitis	5.38e-06	4.38e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—pancreatitis	5.15e-06	4.19e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—pancreatitis	4.81e-06	3.92e-05	CbGpPWpGaD
